Clinical Pharmacokinetics and Metabolism of Bevantolol

Latts, Jeffrey R.
March 1986
Angiology;Mar1986 Part 2, Vol. 37 Issue 3, p221
Academic Journal
Bevantolol (the hydrochloride salt) has pharmacokinetic properties that are clinically advantageous. Bevantolol is well absorbed orally (> 70%); and the systemic bioavailability is 60%. Peak plasma concentrations are achieved 1 to 2 hours following an oral dose. Elimination is first-order with an average elimination half-life of 1.5 hours. Bevantolol exhibits linear pharmacokinetics within the therapeutic range (100 to 400 mg) with no change in half-life with chronic dosing. These properties result in predictable plasma levels and predictable drug response.


Related Articles

  • Three times daily or 8-hourly. Nigam, R.; Loveday, B. J.; Grainger, S. L.; Maxton, D. G. // Journal of the Royal Society of Medicine;Jan1986, Vol. 79 Issue 1, p15 

    The timing of drug ingestion over 24 hours was assessed in 58 outpatients taking drugs three times daily. The mean time between 1st and 2nd dose was 5.7 hours, 2nd and 3rd 6.1 hours and between 3rd and 1st of the next day 12.2 hours. Based on a simulation of hydralazine pharmacokinetics, such...

  • Population pharmacokinetics of topotecan: intraindividual variability in total drug. Montazeri, Ashraf; Boucaud, Maude; Lokiec, François; Pinguet, Frédéric; Culine, Stéphane; Déporte-Féty, Régine; Albin, Nicolas; Laguerre, Brigitte; Goupil, Alain; Bugat, Roland; Canal, Pierre; Chatelut, Etienne // Cancer Chemotherapy & Pharmacology;Nov2000, Vol. 46 Issue 5, p375 

    The inter- and intraindividual variabilities in topotecan clearance (CL) were explored using a population pharmacokinetic approach. Total (lactone + hydroxy acid) topotecan plasma concentrations were obtained in 31 women with metastatic epithelial ovarian cancer treated by the 30-min intravenous...

  • Population Pharmacokinetics.  // Encyclopedic Reference of Molecular Pharmacology;2004, p748 

    An encyclopdia entry for population pharmacokinetics is presented. It refers to the application of pharmacokinetic and statistical methods to sparse data to derive a pharmacokinetic profile of central tendency.

  • Quantitative In Vivo Microdialysis in Pharmacokinetic Studies: Some Reminders. Cano-Cebri�n, M. J.; Zornoza, T.; Polache, A.; Granero, L. // Current Drug Metabolism;Apr2005, Vol. 6 Issue 2, p83 

    This paper reviews the empirical methods of quantitative microdialysis that have been used to interpret the results obtained from pharmacokinetic studies. The concept of extraction efficiency or recovery and the properties of recovery in vivo (variation with flow rate, time dependency and...

  • Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design. Khayat, David; Rixe, Olivier; Brunet, René; Goupil, Alain; Bugat, Roland; Harousseau, Jean-Luc; Ifrah, Norbert; Puozzo, Christian // Cancer Chemotherapy & Pharmacology;Sep2004, Vol. 54 Issue 3, p193 

    As pharmacokinetics represents a bridge between pharmacological concentrations and clinical regimens, the pharmacokinetic exploration of the therapeutic dose range is a major outcome. This study was aimed at assessing pharmacokinetic linearity of i.v. vinorelbine through an open design with...

  • Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Zhou, Shufeng; Kestell, Philip; Tingle, Malcolm D.; Paxton, James W. // Cancer Chemotherapy & Pharmacology;Feb2002, Vol. 49 Issue 2, p126 

    Purposes: Marked gender differences in the pharmacokinetics of many drugs have been reported. For the investigational anticancer drug, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), negligible gender differences in the plasma pharmacokinetics have been observed in mice. The gender effects on the...

  • Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbits. Pavithra, B. H.; Prakash, N.; Jayakumar, K. // Journal of Veterinary Science;2009, Vol. 10 Issue 4, p293 

    investigation was carried out in adult New Zealand white rabbits to study the influence of curcumin pre-treatment on pharmacokinetic disposition of norfioxacin following single oral administration. Sixteen rabbits were divided into two groups of eight each consisting of either sex. Animals in...

  • A Perspective on Reconciling Mass Balance in Forced Degradation Studies. Lukulay, Patrick; Hokanson, Gerard // Pharmaceutical Technology;Oct2005, Vol. 29 Issue 10, p106 

    Focuses on two scenarios that demonstrate the need to use the percent of parent drug loss rather than the percent of degradation products formed when reconciling mass balance calculations. Quality control check on analytical methods to show that all degradation products are adequately detected...

  • Pharmacokinetics. Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p495 

    A definition of the term "pharmacokinetics" is presented. It refers to the study of bodily absorption, distribution, metabolism, and excretion of drugs.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics